Phase II AIDS Malignancy Consortium (AMC) trial of topical halofuginone in AIDS-associated Kaposi’s sarcoma (KS): clinical and biological effects using a novel intra-patient control design

Detalles Bibliográficos
Autores principales: Krown, Susan E, Fingleton, Barbara, Lee, Jeannette Y, Egorin, Merrill J, Koon, Henry B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Meeting Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002724/
http://dx.doi.org/10.1186/1750-9378-5-S1-A62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002724/
http://dx.doi.org/10.1186/1750-9378-5-S1-A62

Ejemplares similares